Email updates

Keep up to date with the latest news and content from BMC Proceedings and BioMed Central.

This article is part of the supplement: International Conference on Prevention & Infection Control (ICPIC 2011)

Open Access Poster presentation

Japan National University Hospitals Infection Control Conference (JNUHICC) report: data summary of device-associated infections

T Watanabe*, S Takakura, Y Tanabe, K Yoshio, S Arakawa and S Ichiyama

  • * Corresponding author: T Watanabe

Author Affiliations

Japan National University Hospitals Infection Control Conference, Nagoya, Japan

For all author emails, please log on.

BMC Proceedings 2011, 5(Suppl 6):P213  doi:10.1186/1753-6561-5-S6-P213


The electronic version of this article is the complete one and can be found online at: http://www.biomedcentral.com/1753-6561/5/S6/P213


Published:29 June 2011

© 2011 Watanabe et al; licensee BioMed Central Ltd.

This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Introduction / objectives

To aggregate separate information into a national database and to enhance quality improvement activities, JNUHICC Sectional Meeting of Surveillance has created a data collection system for device-associated infection rates.

Methods

Data on CLABSI, VAP, and CAUTI occurring between July 2009 and September 2010 were collected from national university hospitals in Japan and were analyzed. A uniform protocol was constructed in accordance with the definitions of NHSN. CLABSI surveillance during the latter study period (from January to September 2010) included data on clinical sepsis (CSEP) and criterion 2-b (one positive blood culture with common skin contaminant and antimicrobial therapy), and the validity of this addition was assessed.

Results

CLABSI data were reported from 20 ICUs, 21 hematology/oncology wards, and 14 gastroenterological surgery wards. The mean rates were 1.14, 2.10, and 1.66 per 1000 device-days (DD), respectively. The rates on the data with the inclusion of CSEP and criterion 2-b were1.93, 2.49, and 2.89, respectively. The VAP rate (reported from 27 ICUs) was 2.38 per 1000 DD. The CAUTI rate (reported from 11 ICUs) was 2.40 (SD 8.84) per 1000 DD. The rate and SD decreased 0.92 and 1.09, respectively, when cases only with asymptomatic bacteriuria (ASB), which consisted of 62% of the CAUTI cases, were excluded.

Conclusion

Indicative and representative values for three major device-associated infection rates at national university hospitals in Japan were obtained. To continue the multi-institutional surveillance of constant quality, analyzing the summary data and reviewing the protocols may be essential.

Disclosure of interest

None declared.